Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pcDNA3.1-HA AKT1 Citations (2)

Originally described in: PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis.
Lee MS, Jeong MH, Lee HW, Han HJ, Ko A, Hewitt SM, Kim JH, Chun KH, Chung JY, Lee C, Cho H, Song J Nat Commun. 2015 Jul 17;6:7769. doi: 10.1038/ncomms8769. PubMed Journal

Articles Citing pcDNA3.1-HA AKT1

Articles
Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells. Chen ZY, Li J, Zhu SD, Li ZD, Yu JL, Wu J, Zhang C, Zeng LH. Exp Ther Med. 2022 Mar;23(3):209. doi: 10.3892/etm.2022.11132. Epub 2022 Jan 7. PubMed
Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. Han X, Mei Y, Mishra RK, Bi H, Jain AD, Schiltz GE, Zhao B, Sukhanova M, Wang P, Grigorescu AA, Weber PC, Piwinski JJ, Prado MA, Paulo JA, Stephens L, Anderson KE, Abrams CS, Yang J, Ji P. J Clin Invest. 2023 Mar 15;133(6):e159638. doi: 10.1172/JCI159638. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.